Long-term effects of nonselective endothelin A and B receptor antagonism in postinfarction rat: Importance of timing

Circulation

Volumn 104, Issue 17, 2001, Pages 2075-2081

  Nguyen, Quang Trinh ^a   Cernacek, Peter ^a   Sirois, Martin G ^a   Calderone, Angelino ^a   Lapointe, Nathalie ^b   Stewart, Duncan J ^b   Rouleau, Jean L ^b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Endothelium derived factors; Myocardial infarction; Remodeling; Survival

Indexed keywords

ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; LU 420627; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOCARDIUM; HEART DILATATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; LONG TERM CARE; MALE; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RAT; SCAR FORMATION; SURVIVAL RATE;

EID: 0035940394     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc4201.097187     Document Type: Article

References (22)

1. Ventricular remodelling after myocardial infarction: Experimental observations and clinical implication
2. Natural history of left ventricular size and function after acute myocardial infarction: Assessment and prediction by echocardiographic endocardial surface mapping
3. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology
4. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction
5. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure
6. Endothelin and endothelin antagonists in hypertension
7. Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction
8. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart
9. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
10. Long-term endothelin receptor antagonist administration improves alterations in expression of various cardiac genes in failing myocardium of rats with heart failure
11. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure
12. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction
13. Role of endogenous endothelin in chronic heart failure: Effects of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
14. Aggravation of left ventricular remodeling by a novel specific endothelin ET(A) antagonist EMD94246 in rats with experimental myocardial infarction
15. Endothelin A receptor blockade causes adverse left ventricular remodeling but improves pulmonary artery pressure after infarction in the rat
16. Blocking of the endothelin system: The development of receptor antagonists
17. Radioreceptor assay of an endothelin A receptor antagonist in plasma and urine
18. Discovery and synthesis of (S)-3-[2-(3,4-dimethoxyphenyl)ethoxy]-2-(4,6-dimethylpyrimidin-2-yloxy) -3,3-diphenylpropionic acid (LU 302872), a novel orally active mixed ET(A)/ET(B) receptor antagonist
19. Characterization of two new ETB selective radioligands, [1251]-BQ3020 and [1251]-[Ala1,3,11,15]ET-1 in human heart
20. Markedly different effects on ventricular remodelling result in a decrease in inducibility of ventricular arrhythmias
21. Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent
22. Crosstalk between endothelin and nitric oxide in the control of vascular tone